LAGLOVE (M) SDN – Trademark Portfolio

Entity Type: 03

LAGLOVE (M) SDN holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include INTERCEPT, GET A GRIP, TOUCH & GO, FIRST DEFENSE, and INTERCEPT ELITE. The owner is based in KAJANG.

OFF BATU 13, LALAN CHERAS

KAJANG 4300 , MY

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

LAGLOVE (M) SDN's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does LAGLOVE (M) SDN have?

LAGLOVE (M) SDN has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 cancelled.

What trademark classes does LAGLOVE (M) SDN file in?

LAGLOVE (M) SDN files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are LAGLOVE (M) SDN's most well-known trademarks?

LAGLOVE (M) SDN's registered trademark portfolio includes well-known marks such as INTERCEPT, GET A GRIP, TOUCH & GO, FIRST DEFENSE, and INTERCEPT ELITE. These are among 5 currently registered trademarks in the portfolio.

What is LAGLOVE (M) SDN's trademark registration success rate?

LAGLOVE (M) SDN has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.